已完成300例脑机接口手术？三博脑科：假的

Core Viewpoint - Sanbo Brain Science (301293.SZ) experienced a significant stock fluctuation, initially narrowing its gains by nearly 2% before rebounding strongly, maintaining a volatile trading pattern. The stock had previously hit the daily limit of 20% on January 5 and 6 due to speculation surrounding its status in the brain-computer interface sector [1]. Group 1 - Sanbo Brain Science is identified as a brain-computer interface concept stock, which has attracted attention due to its recent stock performance [1]. - The company has been the subject of online rumors claiming it is the "only private hospital group in China approved for clinical implantation of brain-computer interfaces," and that it has completed 300 brain surgeries [1]. - A representative from Sanbo Brain Science clarified that the claim regarding being the "only approved private hospital group" is inaccurate and that the information circulating is a mix of various details [1]. Group 2 - The company also denied the claim of having completed 300 brain surgeries, labeling it as false information [1].